We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: R2673
CAS No: 1831064-63-1
Synonyms/Alias: CPP9;CHEMBL4754257;EX-A10042;HY-P10644;1831064-63-1;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C51H76N20O8 |
M.W/Mr. | 1097.3 |
Sequence | Three Letter Code:cyclo[2Nal-Arg-D-Arg-Arg-D-Arg-Gln-D-Phe] |
InChI | InChI=1S/C51H76N20O8/c52-40(72)21-20-37-45(77)70-38(27-29-10-2-1-3-11-29)47(79)71-39(28-30-18-19-31-12-4-5-13-32(31)26-30)46(78)68-36(17-9-25-64-51(59)60)43(75)66-34(15-7-23-62-49(55)56)41(73)65-33(14-6-22-61-48(53)54)42(74)67-35(44(76)69-37)16-8-24-63-50(57)58/h1-5,10-13,18-19,26,33-39H,6-9,14-17,20-25,27-28H2,(H2,52,72)(H,65,73)(H,66,75)(H,67,74)(H,68,78)(H,69,76)(H,70,77)(H,71,79)(H4,53,54,61)(H4,55,56,62)(H4,57,58,63)(H4,59,60,64)/t33-,34+,35+,36-,37-,38+,39-/m0/s1 |
InChI Key | WVBOCYPQZGZLLP-KNEAGCMXSA-N |
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com